Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
10/2003
10/15/2003CN1124276C Rapamycin derivatives
10/14/2003US6632923 Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
10/14/2003US6632836 To treat autoimmune disorders, cardiac arrhythmias and the like
10/14/2003US6632834 Compositions and methods for treating conditions responsive to estrogen
10/14/2003US6632819 Antiviral azaindole derivatives
10/14/2003US6632809 Gyrase inhibitors and uses thereof
10/14/2003US6632794 Insulin-like growth factor agonist molecules
10/14/2003US6632789 Contacting with inhibitor or activator of phosphatidylinositol 3-kinase
10/14/2003US6632648 Methods of terminal sterilization of fibrinogen
10/14/2003US6632628 Use to detect compounds having therapeutic activity toward cardiac hypertrophy
10/14/2003US6632453 Ciprofoxacin-metronidazole antibiotic composition
10/14/2003US6632449 Compositions and kits comprising a defined boron compound and methods of their preparation
10/14/2003US6632447 Estrogen receptor modulator (SERM): Tamoxifen Citrate and Raloxifene, and Faslodex (Antiestrogen), reducing the amount of high grade prostate intraepithelial neoplasia lesions
10/14/2003US6632445 Unit dosage forms for the treatment of herpes simplex
10/14/2003US6632440 Chronic obstructive pulmonary disease (COPD), asthma; Aerosol administration a compound that inhibits exocytosis in mucus secreting cells produced by modifying a clostridial neurotoxin
10/14/2003US6632430 Administering enzyme inhibitors of S-adenosyl methionine synthetase (SAMS), of S-adenosyl homocysteine hydrolase (SAHH) and of transmethylases, RNA transmethylase and DNA transmethylase; antidotes; detoxification
10/14/2003CA2385777A1 Use of anti-tnf.alpha.antibodies and another drug
10/14/2003CA2184747C Benzamide analogs, useful as parp (adp-ribosyltransferase, adprt) dna repair enzyme inhibitors
10/14/2003CA2098242C Surface modified anticancer nanoparticles
10/09/2003WO2003083485A2 Protein for use in hypoxia related conditions
10/09/2003WO2003083436A2 Fibrinogen binding moieties
10/09/2003WO2003083135A2 Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 2 (npff2)
10/09/2003WO2003083067A2 Histone deacetylase inhibitors for the treatment of multiple sclerosis, amyotrophic lateral sclerosis and alzheimer's disease
10/09/2003WO2003083050A2 Human deubiquitinating protease gene on chromosome 7 and its murine ortholog
10/09/2003WO2003083039A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/09/2003WO2003082926A2 Antimicrobial polymer conjugates
10/09/2003WO2003082869A1 Azaindoles as inhibitors of c-jun n-terminal kinases
10/09/2003WO2003082841A1 5-substituted 1,1-dioxo-`1,2,5!thiazolidine-3-one derivatives as ptpase 1b inhibitors
10/09/2003WO2003082825A1 Use of an alfa2-adrenoreceptor antagonist for cns-related diseases
10/09/2003WO2003082392A2 Oxygenating agents for enhancing host responses to microbial infections
10/09/2003WO2003082372A2 Chemiluminescent treatment of acne
10/09/2003WO2003082370A2 Transcellular drug delivery system
10/09/2003WO2003082360A1 Drug delivery particle
10/09/2003WO2003082359A1 Tissue treatment
10/09/2003WO2003082358A1 Use of glass and/or glass ceramics in the form of powder or fibers for the controlled release of ions
10/09/2003WO2003082348A1 Nanogel networks including polyion polymer fragments and biological agent compositions thereof
10/09/2003WO2003082338A1 Remedies for glomerular diseases
10/09/2003WO2003082337A1 Combination comprising a cdk inhibitor and doxorubicin
10/09/2003WO2003082336A1 Female birth control method
10/09/2003WO2003082323A1 A composition and method for killing of tumours
10/09/2003WO2003082322A1 A method of modulating cellular activity
10/09/2003WO2003082314A2 Diagnostics and therapeutics for diseases associated with n-formyl peptide receptor like 1 (fprl1)
10/09/2003WO2003082304A1 Antimicrobial compositions and methods of use
10/09/2003WO2003082299A1 Improved hormone replacement therapy
10/09/2003WO2003082296A1 Use of methylene blue and related compounds to prevent or reverse an exaggerated hemodynamic reaction
10/09/2003WO2003082283A2 Pharmaceutical composition with combined active agents and methods for using the same
10/09/2003WO2003082273A1 Solubilization of weak bases
10/09/2003WO2003082272A1 Substituted benzazoles and use thereof as raf kinase inhibitors
10/09/2003WO2003082269A1 Use of statins and other immunomodulatory agents in the treatment of autoimmune disease
10/09/2003WO2003082267A1 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy
10/09/2003WO2003082266A1 Use of topoisomerase inhibitors and heat shock protein 90 inhibitors for use in chemotherapy
10/09/2003WO2003082260A2 Tuberculosis treatment using pleuromutilin derivatives
10/09/2003WO2003082255A2 Use of mob-5 in pain
10/09/2003WO2003082239A1 Use of compatible solutes for inhibiting the release of ceramides
10/09/2003WO2003082227A1 Melanogenesis regulator
10/09/2003WO2003082216A2 Neuroprotectant methods, compositions, and screening methods thereof
10/09/2003WO2003082211A2 Synergy of dopamine d2 and adenosine a2 receptors activates pka signaling via beta/gamma dimers
10/09/2003WO2003082208A2 Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders
10/09/2003WO2003082207A2 Volume efficient controlled release dosage form
10/09/2003WO2003082198A2 Methods of treatment with lxr modulators
10/09/2003WO2003082197A2 Immunosuppressant compounds, methods and uses related thereto
10/09/2003WO2003082196A2 Combination therapy using trefoil peptides
10/09/2003WO2003082191A2 Substituted 2,3-diphenyl pyridines
10/09/2003WO2003082189A2 Method for producing pseudo islets
10/09/2003WO2003082186A2 Use of benzimidazole analogs in the treatment of cell proliferation
10/09/2003WO2003082139A1 Dispensing apparatus and cartridge
10/09/2003WO2003049804A3 Treatment of genitourinary tract disorders
10/09/2003WO2003045405A3 Lactic acid bacteria and their use for treating and preventing cancer
10/09/2003WO2003043570A3 Formulations and methods for treatment or amelioration of inflammatory conditions
10/09/2003WO2003035048A3 Methods for the treatment of osteoarthritis and compositions thereof
10/09/2003WO2003013534A3 Methods for the treatment of cancer with irinotecan based on cyp3a5
10/09/2003WO2003013533A3 Methods for improved treatment of cancer with irinotecan based on mrp1
10/09/2003WO2003007889A3 Therapeutic agents comprising pro-apoptotic proteins
10/09/2003WO2003006893A3 Methods of inhibiting amyloid toxicity
10/09/2003WO2002092011A3 Methods of treating antibody-mediated pathologies using agents which inhibit cd21
10/09/2003WO2002090934A3 Evaluation of ultraviolet radiation damage to skin using new genemarkers, methods and compositions related thereto
10/09/2003WO2002087503A3 Compositions and methods for treating colorectal polyps and cancer
10/09/2003WO2002069947A3 Antisense oligonucleotides and trichostatin analogue histone deacetylase-4 inhibitors against cancer
10/09/2003WO2002069905A3 Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-amp associated disorders
10/09/2003WO2002067928A3 Metronomic dosing of taxanes for inhibiting tumor growth
10/09/2003WO2002060955A3 Modified antibodies and methods of use
10/09/2003WO2002059154A3 Neutralizing human monoclonal antibodies against hiv-1, their production and uses
10/09/2003WO2002053743A3 Mammalian tribbles signaling pathways and methods and reagents related thereto
10/09/2003WO2002038797A3 Modulators of bruton's tyrosine kinase, their identification and use
10/09/2003WO2002034284A3 Methods of therapy for hiv infection
10/09/2003WO2002033099A3 Human kinases
10/09/2003WO2002026245A3 Use of serp-1 in combination with an immunosuppressant for influencing inflammatory and immune reactions
10/09/2003WO2002016636A3 Diagnostic and therapeutic use of a caveolae-associated integral membrane protein for alzheimer's disease and related neurodegenerative disorders
10/09/2003WO2002010382A3 Trp8, trp9 and trp10, markers for cancer
10/09/2003US20030191187 Aqueous solution containing phosphate; adjustment pH
10/09/2003US20030191177 Maintenance dosage of beta blocker; cardiovascular disorders
10/09/2003US20030191172 Method of using cyclooxygenase inhibitors and antimuscarinic agents
10/09/2003US20030191159 Antisecretory agents; antiulcer agents; adjust absorption
10/09/2003US20030191149 Compounds for treating fibromyalgia and chronic fatigue syndrome
10/09/2003US20030191147 Alcoholism, drug abuse, antidepressants
10/09/2003US20030191117 Acyclic piperazine and piperidine derivatives
10/09/2003US20030191116 Gastrin and cholecystokinin receptor ligands (III)
10/09/2003US20030191114 Binding to ligand; induce signals
10/09/2003US20030191102 Contraception method using competitive progesterone antagonists and novel compounds useful therein
10/09/2003US20030191100 Hypotensive agents; cardiovascular disorders; administering spironolactone
1 ... 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 ... 1151